Breakthrough Technology for the Treatment of Lung Cancer
Sanovas is an innovative biotech company that has developed a pioneering platform of therapy enabling technologies that provide surgeons with faster, less invasive, lower risk and more cost effective interventional treatments. Sanovas has developed this comprehensive platform of breakthrough solutions using the company's Vas Zeppelin Clear Vessel Technology, that will advance the capabilities of Interventional Science, for the benefits of both surgeons and patients.
|
We invite you to watch our informative Pulmonary Anatomy video: |
With access to our Investor Portal, you can also view a Sanovas Technology video: |
|
|
|
| If you are interested in exploring an investment in Sanovas, go here to request access to the Sanovas Investor Portal and view the cutting edge technology we've developed, as we start by working towards saving the lives of those with pulmonary diseases. Click the thumbnail above to play the Pumonary Anatomy video, and if you are logged in with approved Investor portal access, you can also click the Sanovas Technology image to view that video. |
|
Watch Now!
Sanovas Featured on Profiles TV
In this episode of the Profiles TV show, host Terry Bradshaw takes a look at Sanovas. The show includes interviews with Senator Dianne Feinstein, Dr. Rex Yung from Johns Hopkins University, Dr. Gerard Silvestri, President of the American Association of Bronchology and Sanovas CEO, Larry Gerrans.
News
- Sanovas Takes on Lung Cancer with a Suite of New Technologies - Part 1 of 2
- Sanovas Takes on Lung Cancer with a Suite of New Technologies - Part 2 of 2
- Larry Gerrans comments on CFO.com
- Larry Gerrans comments on Forbes jobs article
- Larry Gerrans comments on VentureBeat article
- Larry Gerrans comments on Forbes article
- Sanovas Remarks on "How Crowdfunding Affects the Healthcare Market, and Your Wallet"
Sanovas Targeting the Last Frontier of Interventional Sciences
Among the technologies the firm has developed what it hails the world’s smallest endoscopic steerable camera.
Sanovas (Sausalito, CA) is a company founded on bold ambition. “Only so often in life does the opportunity to leave a footprint on the legacy of mankind come along,” reads a quote in the company’s shareholder’s report from the first quarter of 2012. And the firm takes those words seriously, having collaborated for years with interventional pulmonologists, to give hope to patients suffering from chronic lung diseases such as lung cancer and chronic obstructive pulmonary disorder (COPD). Lung cancer is the deadliest all cancers. In the United States, it claims the lives of nearly 400,000 people annually, according to the American Lung Association. COPD is the third leading cause of death in the country. [Read more...]
Published: May 3, 2012 on mddionline.com by: Brian Buntz
